Stay Ahead of the Game With Astrazeneca (AZN) Q2 Earnings: Wall Street's Insights on Key MetricsZacks Investment Research • 07/22/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AstraZeneca PLC- AZNGlobeNewsWire • 07/21/26
Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research • 07/20/26
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?24/7 Wall Street • 07/17/26
AZN Inks Deal With Dizal to In-License Rights to Lung Cancer DrugZacks Investment Research • 07/15/26
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving AstraZeneca (AZN)GlobeNewsWire • 07/14/26
AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 BillionWSJ • 07/14/26
AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN)Business Wire • 07/13/26
AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center StageMarketBeat • 07/11/26
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?CNBC • 07/11/26
AZN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving AstraZenecaPRNewsWire • 07/10/26
AstraZeneca Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into AstraZeneca (AZN)PRNewsWire • 07/10/26